BOSTON, Aug. 17, 2011 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, has been named Company of the Year for the Pharmaceutical Industry in The Eighth Annual International Business Awards, the only global, all-encompassing business awards program honoring great performances in business. PAREXEL was recognized for helping its global client base increase the efficiency of clinical trials, access emerging markets, and speed new medical treatments to patients.
PAREXEL was selected as Company of the Year for the Pharmaceutical Industry by an independent panel of internationally-based judges. The Company was honored for transforming its business to deliver best-practice strategic partnering models that leverage its global resources and worldwide technology infrastructure. PAREXEL, which announced strategic partnerships over the past year with Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Merck, and Pfizer, was recognized for its leadership in bringing more effectiveness to biopharmaceutical development.
"We are honored to be recognized by the judges of The International Business Awards. This award is a tribute to the expertise of our employees who provide innovative solutions to help our clients accomplish their product development goals. We share a vision with our clients to bring healthcare improvements to patients around the world. All of us at PAREXEL are committed to advancing the success of the biopharmaceutical industry in our mission to prevent and cure disease," said Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL International.
In addition to the recognition of Company of the Year for the Pharmaceu
|SOURCE PAREXEL International Corporation|
Copyright©2010 PR Newswire.
All rights reserved